Joe Farago News Today : Breaking News, Live Updates & Top Stories | Vimarsana

There’s no question that Canadians value their private health benefits, even with pharmacare discussions back on the table. In a recent Abacus Data study, 78 per cent of respondents said they feel group benefits plans increase the availability and affordability of health services in Canada, as opposed to undermining universal health coverage. Furthermore, 92 per […]

Amid plans by the federal government to introduce national dental and pharmacare programs, key stakeholders in the private payer health-care sector should highlight the value of private health plans in Canada, according to a panel during a webinar by the Group Insurance Pharmaceutical Committee last week. In March, the Liberal Party and the New Democratic […]

The proposed amendments to the patented medicines regulations by the Patented Medicine Prices Review Board could have a big impact on both the group insurance and pharmaceutical industry. “The CLHIA is very supportive of PMPRB adjustments that may be coming,” said Joan Weir, director of health and disability policy at the Canadian Life and Health […]

Innovative Medicines Canada / Médicaments novateurs Canada: New IMC Report Shows Impact of Chronic Disease and Increased Claims on Private Drug Plans 2016-2019 Analysis of Private Drug Claim Cost Drivers report, released today. The report also finds that drug claim costs are rising at approximately 5% annually, less than half of the 11% that insurers have projected. The report demonstrates that the major cost increases to private health benefit plans in Canada are a result of increased drug utilization due to the growth in chronic diseases, like diabetes, requiring access to more medications...